United Kingdom Archives

News and Trends 30 Sep 2014

New Collaboration for New Cancer Therapies

Medimmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca, has entered into a collaboration to establish a joint lab in Cambridge, UK, with Cancer Research Technology, the commercial arm of Cancer Research UK. The new laboratory will be the first partnership of its kind of both organizations, and will focus on […]

September 30, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 18 Sep 2014

Would you be interested by MinION, the first pocket DNA sequencer ?

The first next-gen sequencing device of the size of an iPhone has been shipped. It is called MinION and is developed by the Oxford-based company Nanopore technologies. The long research and development process has finally paid off. How can a next-gen sequencer hold in a so small device? It uses a newly developed nanopore sequencing method. […]

September 18, 2014 - 3 minutesmins - By Philip Hemme

Sophia Genetics is the first European bioinformatic company allowed to analyze clinical genetic data

News and Trends 17 Sep 2014

Sophia Genetics: the first European bioinformatic company allowed to analyze clinical genetic data

Sophia Genetics has become the first European company to obtain a CE-IVD mark allowing the use of their bioinformatic algorithms to analyse clinical data obtained through Next Generation Sequencing. This certification is an important step in making these in the standard use of routine genetic testing and clinical diagnosis. It brings Sophia Genetics’ world-leading Data Driven Medicine platform to […]

September 17, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 1 Sep 2014

Fighting prostate cancer with a tomato-rich diet

Men who eat over 10 portions a week of tomatoes have an 18 per cent lower risk of developing prostate cancer, new research suggests. With 35,000 new cases every year in the UK, and around 10,000 deaths, prostate cancer is the second most common cancer in men worldwide. Rates are higher in developed countries, which […]

September 1, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 27 Aug 2014

Synpromics successfully use synthetic biology in plant science projects

Synpromics, a Scottish-based synthetic biology company today announced that it has successfully generated several highly effective synthetic promoters for use in plants. Dr Michael Roberts, Founder and CSO, said: “We have now shown that our highly disruptive technology platform can be extended from human life science into plant science. Whilst this was always expected, we […]

August 27, 2014 - 2 minutesmins - By Joachim Eeckhout

News and Trends 25 Aug 2014

KalVista start the clinical development of a new treatment for diabetic macular edema

KalVista Pharmaceuticals, an ophthalmology company with a focus on diabetic macular edema (DME), today announces that it has begun a Phase I, First in Human, trial of its novel plasma kallikrein inhibitor, KVD001, for the treatment of DME. The study’s principal investigator is Dr. Jennifer K Sun of the Beetham Eye Institute, Joslin Diabetes Center. […]

August 25, 2014 - 3 minutesmins - By Joachim Eeckhout

News and Trends 19 Aug 2014

GSK abandon its joint drug project with Galapagos

According to Reuters, Galapagos, a Belgian biotech group announced that GlaxoSmithKline has stopped a joint drug development project over concerns about adverse effects. In June 2006, Galapagos signed a broad alliance with GSK to discover and develop breakthrough medicines. This multi-target, multi-year alliance runs from target discovery through to delivery of a clinical Proof of Concept. […]

August 19, 2014 - 2 minutesmins - By Joachim Eeckhout

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us